Genes and pathophysiology of type 2 diabetes: more than just the Randle cycle all over again

被引:21
作者
Shuldiner, AR
McLenithan, JC
机构
[1] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA
[2] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Baltimore, MD 21218 USA
关键词
D O I
10.1172/JCI200423586
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The Randle cycle, which has been invoked to explain the reciprocal relationship between fatty acid oxidation and glucose oxidation, has long been implicated as a potential mechanism for hyperglycemia and type 2 diabetes mellitus (T2DM). Now genetic, functional genomic, and transgenic approaches have identified PPARgamma coactivators (PGC-1alpha and PGC-1beta) as key regulators of mitochondrial number and function. They regulate adaptive thermogenesis as well. as glucose and fat oxidation in muscle and fat tissue, gluconeogenesis in liver, and even glucose-regulated insulin secretion in betacells. PGC-1alpha and PGC-1beta mRNA levels and the mitochondrial genes they regulate are decreased in muscle of people with prediabetes and T2DM. A new report indicates that PGC-1alpha and PGC-lbeta mRNA levels decrease with age in individuals with a genetic variant in PGC-lalpha, and these decreases correlate with alterations in whole-body glucose and fatty acid oxidation (see the related article beginning on page 1518). These findings provide insights into how aging modifies genetic susceptibility to alterations in oxidative phosphorylation and T2DM.
引用
收藏
页码:1414 / 1417
页数:4
相关论文
共 32 条
[1]   AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34 [J].
Agarwal, AK ;
Arioglu, E ;
de Almeida, S ;
Akkoc, N ;
Taylor, SI ;
Bowcock, AM ;
Barnes, RI ;
Garg, A .
NATURE GENETICS, 2002, 31 (01) :21-23
[2]   The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes [J].
Altshuler, D ;
Hirschhorn, JN ;
Klannemark, M ;
Lindgren, CM ;
Vohl, MC ;
Nemesh, J ;
Lane, CR ;
Schaffner, SF ;
Bolk, S ;
Brewer, C ;
Tuomi, T ;
Gaudet, D ;
Hudson, TJ ;
Daly, M ;
Groop, L ;
Lander, ES .
NATURE GENETICS, 2000, 26 (01) :76-80
[3]   Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy [J].
Cao, H ;
Hegele, RA .
HUMAN MOLECULAR GENETICS, 2000, 9 (01) :109-112
[4]   THE TRIUMVIRATE - BETA-CELL, MUSCLE, LIVER - A COLLUSION RESPONSIBLE FOR NIDDM [J].
DEFRONZO, RA .
DIABETES, 1988, 37 (06) :667-687
[5]   Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus [J].
Ek, J ;
Andersen, G ;
Urhammer, SA ;
Gæde, PH ;
Drivsholm, T ;
Borch-Johnsen, K ;
Hansen, T ;
Pedersen, O .
DIABETOLOGIA, 2001, 44 (12) :2220-2226
[6]   Perspective: The search for genes for type 2 diabetes in the post-genome era [J].
Elbein, SC .
ENDOCRINOLOGY, 2002, 143 (06) :2012-2018
[7]   Mechanisms of disease: Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. [J].
Fajans, SS ;
Bell, GI ;
Polonsky, KS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (13) :971-980
[8]   Medical progress - Acquired and inherited lipodystrophies [J].
Garg, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1220-1234
[9]   Large-scale association studies of variants in genes encoding the pancreatic β-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes [J].
Gloyn, AL ;
Weedon, MN ;
Owen, KR ;
Turner, MJ ;
Knight, BA ;
Hitman, G ;
Walker, M ;
Levy, JC ;
Sampson, M ;
Halford, S ;
McCarthy, MI ;
Hattersley, AT ;
Frayling, TM .
DIABETES, 2003, 52 (02) :568-572
[10]   FETAL AND INFANT GROWTH AND IMPAIRED GLUCOSE-TOLERANCE AT AGE 64 [J].
HALES, CN ;
BARKER, DJP ;
CLARK, PMS ;
COX, LJ ;
FALL, C ;
OSMOND, C ;
WINTER, PD .
BMJ-BRITISH MEDICAL JOURNAL, 1991, 303 (6809) :1019-1022